Trial intelligence / Profile preview

Fitostimoline versus Tantum Rosa for nonspecific vaginosis/vaginitis

2008-005007-26Phase 4Completed

Sponsor
Farmaceutici Damor
Start
Oct 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of triticum vulgare aqueous extract and benzydamine in bacterial vaginosis (BV), vaginitis and Vulvovaginitis (3 arms), sponsored by Farmaceutici Damor. Primary endpoint: Therapeutic success. Started Oct 2008; status: completed.

02

Drugs

triticum vulgare aqueous extractbenzydamine
03

Conditions

bacterial vaginosis (BV)vaginitisVulvovaginitis

Beyond the preview

Go deeper on 2008-005007-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005007-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call